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Purpose: To characterize the histological changes that occur in response to induction of ischemic or mechanical optic
nerve damage in transgenic mice.
Methods: Either optic nerve crush injury or rodent anterior ischemic optic neuropathy (rAION) were induced in the right
eye of mice transgenic for the Thy1 gene promoter expressing cyan fluorescent protein (CFP; n=40) and mice transgenic
for the cyclic nucleotide phosphodiesterase (CNPase) gene promoter expressing green fluorescent protein (GFP; n=40).
The left eye served as a control. The mice were euthanized at different times after injury. Eyes were enucleated, and the
brain together with the optic nerves was completely dissected. Cryopreserved sections of both optic nerves were analyzed
by fluorescence microscopy. In addition, flat-mounted retinas from the Thy1-CFP mice were analyzed for retinal ganglion
cell (RGC) loss.
Results: Axonal loss was detected in the right eye of the Thy1-CFP mice, and demyelination was detected in the CNPase-
GFP mice. Both processes occurred simultaneously in the two models of injury. The damage proceeded retrogradely and,
in the crush-injury group, crossed the chiasm within 4 days. At 21 days after injury, RGC loss measured 70% in the crush-
injury group and 25% in the rAION group.
Conclusions: Axonal injury and demyelination along the optic nerves occur simultaneously in transgenic mice exposed
to ischemic or crush injury. The degree of RGC loss reflects the severity of the injury. Loss of oligodendrocytes and myelin
apparently leads to axonal loss. Transgenic mice offer a promising model for exploring the damage caused by optic nerve
injury. Use of fluorescence labeling makes it possible to better understand the underlying pathophysiology, which can
help researchers formulate neuroprotective agents.
Optic nerve injury causes severe axonal damage leading
to  apoptosis  of  the  retinal  ganglion  cells  (RGCs)  and
consequent loss of vision [1-3]. The mechanisms of axonal
damage have been examined in different animal models: optic
nerve transection and crush [4-6]; acute retinal ischemia and
reperfusion [7-9]; chronic elevation of intraocular pressure
(IOP)  [10-12];  and  rose-bengal-photoactivation-induced
anterior ischemic optic neuropathy (AION) [12,13].
Studies  in  mice  transgenic  for  the  c-fos  gene  have
reported that the induction of AION in rodent led to overall
axonal loss, with variations in the severity of RGC loss in the
retina from region to region [14]. Progressive oligodendrocyte
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stress and demyelination were detected along the injured optic
nerve [13]. These findings suggested that in optic nerve injury,
RGC loss and axonal involvement occur simultaneously with
oligodendrocyte stress, which proceeds rapidly through the
chiasm [13]. Oligodendrocytes are known to be essential for
neuronal cell body and axonal survival as well as for myelin
assembly [15]. Given that a single oligodendrocyte myelinates
many  axons  [15,16],  under  ischemic  conditions
demyelination may lead to additional loss of function also in
axons in the proximity of the injury and to additional RGC
death. A blockage in axonal transportation as well may further
increase the damage and RGC death. At the same time, the
RGC loss itself can cause axonal degeneration with associated
oligodendrocyte dysfunction and consequent demyelination.
It is not yet clear whether it is the loss of the oligodendrocytes
that causes the axonal breakdown or if the axonal loss leads
to oligodendrocyte death, or both. These axonal and myelin
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2171changes  have  not  been  examined  specifically  in  labeled
transgenic mice at different intervals after injury.
Thy1, a surface glycoprotein, is uniquely expressed by
ganglion cells in the retina [17] and has been found to serve
as a useful marker of RGC loss and axonal damage. Studies
of optic nerve injury have shown a decrease in expression of
the Thy1 gene or a depletion of the Thy1 protein following
optic nerve damage [18], indicating early stress to the RGCs
[18-20].  However,  these  studies  did  not  elaborate  on  the
association of axonal loss with demyelination.
The 2',3′-cyclic nucleotide 3′-phosphodiesterase enzyme
(CNPase) is involved in myelin synthesis and is present in
high levels in brain and peripheral nerves [21]. It is found
almost exclusively in the myelin-producing oligodendrocyte
cells in the central nervous system. Therefore, CNPase can be
used as a marker for oligodendrocyte integrity [22]. Reduced
CNPase levels have been reported in various neurologic and
demyelinating diseases [23,24]. The aim of the present study
was to further characterize the pathophysiologic processes
underlying  the  axonal  and  myelin  optic  nerve  changes  in
response to injury of differing severity in transgenic Thy1 and
CNPase mice.
METHODS
Animals: All protocols were conducted in accordance with the
ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research and were approved and monitored by the
Animal  Care  Committee  of  Rabin  Medical  Center,  Petah
Tiqwa, Israel. The animals were housed under a 14 h:10 h
light-dark cycle with standard chow and water ad libitum.
All mice included in the study (n=100; 80 transgenic, 20
nontransgenic for apoptosis assay) were at least 2 months old
and weighed more than 25 g. We induced crush injury in 40
mice and rodent anterior ischemic optic neuropathy (rAION)
in 40 mice. All mice were analyzed accordingly. Findings
were  evaluated  in  transgenic  Thy1  mice  labeled  for  cyan
fluorescent protein (CFP; Thy1-CFP transgenic mice were
kindly  provided  by  Dr.  Steven  Bernstein,  University  of
Maryland,  Baltimore,  MD)  and  transgenic  CNPase  mice,
labeled  for  green  fluorescent  protein  (GFP;  CNPase-GFP
transgenic mice were obtained from Dr. Vittorio Gallo, Center
for  Neuroscience  Research,  Children's  Research  Institute,
Washington, D.C.). Transgenes were verified by polymerase
chain reaction using gene-specific primers and genomic DNA.
Induction of crush injury: Using 80 mg/kg ketamine and 4 mg/
kg xylazine, we anesthetized 20 Thy1-CFP and 20 CNPase-
GFP transgenic mice. We then crushed the right optic nerve
in each mouse by applying forceps at 2.5–3.0 mm posterior to
the globe for 7 s; this procedure was performed 3 times. The
left eyes were not treated and served as controls. Subsets of
mice in each group were euthanized by carbon dioxide (CO2)
asphyxiation at 1, 3, 4, 7, 14, and 21 days after injury. The
eyes were enucleated and the brain together with the optic
nerves was completely dissected. Cryopreserved sections of
brain,  chiasm,  and  both  optic  nerves  were  analyzed  by
fluorescence microscopy. In addition, flat-mounted retinas
from the Thy1-CFP mice were analyzed for RGC loss.
Induction  of  rAION:  rAION  was  induced  as  previously
described  [13].  In  brief,  20  mice  from  each  group  were
anesthetized with 80 mg/kg ketamine and 4 mg/kg xylazine,
and the right pupils were dilated with eyedrops of 0.25%
phenylephrine  hydrochloride  and  0.5%  tropicamide
(Mydramid).  A  custom-designed,  plastic  fundus,  corneal
contact lens was used for direct visualization of the retina and
optic nerve head. After intravenous administration of 0.05 ml
of 2.5 mM rose bengal in phosphate-buffered saline (PBS X1,
Biological Industries, Ltd., Kibbutz Beit Haemek, Israel), the
right optic nerve head was illuminated with argon green laser
Figure 1. Axonal loss in optic nerves of Thy1-CFP mice at various intervals after crush injury. A: Control optic nerve; no damage. Note the
absence of damage to the optic nerve. B: Four days after crush injury; 30% axonal loss can be detected. C: Fourteen days after crush injury;
maximal (75%) axonal loss is seen. Note the central loss of Thy1-CFP-labeled axons.
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eyes did not undergo laser activation and served as controls.
Subsets of animals were euthanized at 1, 3, 4, 7, 14, and 21
days after rAION induction. The eyes were enucleated, and
the  brain  together  with  the  optic  nerves  was  completely
dissected. Cryopreserved sections of both optic nerves were
analyzed  by  fluorescence  microscopy.  In  addition,  flat-
mounted retinas of the Thy1-CFP mice were analyzed for
RGC loss.
Apoptosis  assay:  Longitudinal  cross-sections  of  the
cryopreserved eyes and optic nerves were cut 6 µm thick for
in situ TdT-mediated dUTP nick end labeling assay (TUNEL;
Roche, Mannheim, Germany). Staining was performed with
the fluorescein-tagged apoptosis detection system. Hoechst
stain  was  used  to  identify  nuclear  changes.  Results  were
analyzed  with  a  fluorescence  microscope  (Fluoview  X;
Olympus, Tokyo, Japan) at 580 nm wavelength. The mean
number of TUNEL-positive cells per slide was determined in
consecutive sections; special attention was addressed to the
specific retinal layer. Findings were compared between the
study eyes and control eyes at the different time points and
between the models of optic nerve injury.
TABLE 1. THE CRUSH MODEL: LOSS OF CELLS IN THE RETINA AND OPTIC NERVE OVER TIME.
 
 
 
4 days 
(±SD)
7 days
(n=10) %
(±SD)
14 days 
(n=10) % 
21 days 
(n=10) %
Retina
 
Thy1-CFP mice
(n=40)
CFP 27.4 (±8.7) 58.6 (±11.3) 77.0 (±6.1) 77.4 (±7.4)
Hoechst 17.2 (±7.6) 47.5 (±5.1)               69.1 (±2.4) 69.5 (±3.3)
Optic
nerve
CNPase-GFP mice
(n=40)
GFP 28.7 (±6.3) 37.2 (±5.2) 45.2 (±11.6) 52.3 (±8.6)
Hoechst 31.6 (±6.9)              43.7 (±3.4)             47.7 (±4.3)              51.1 (±5.3)
Comparison of cell loss in the retina and optic nerve in crush injury, by fluorescence labeling of the transgenic mice (CFP or
GFP)  versus nuclei staining (Hoechst), at different time points. Abbreviations: Thy1, a surface glycoprotein (Thy1); cyan
fluorescence protein (CFP); 2', 3′-cyclic nucleotide 3′-phosphodiesterase enzyme (CNPase); green fluorescence protein (GFP);
standard deviation (SD).
Figure  2.  RGC  loss  in  flat-mounted
retinas  of  Thy1-CFP  mice  at  various
intervals after crush injury. A: Control
retina; no damage is detected. B: Four
days after crush injury; approximately
20%–30% RGC cell loss was detected.
C: Seven days after crush injury; 50%
RGC  loss  was  detected.  D:  Fourteen
days after crush injury; maximal 75%
RGC  loss  can  be  detected.  Note  the
diffuse loss of the labeled cells.
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 (±SD) (±SD)
(n=10) %Figure 3. Oligodendrocyte cell loss in chiasm and optic nerves of
CNPase-GFP  mice  at  various  intervals  after  crush  injury.  A:
Fourteen  days  after  crush  injury;  approximately  50%
oligodendrocyte loss in right optic nerve (white arrow) as compared
to the left optic nerve. Note the thin right optic nerve and the reduced
fluorescence signal in the right axonal fibers crossing the chiasm
toward the contralateral lateral geniculate body. B Ipsilateral (right)
and C contralateral (left) lateral geniculate body (LGB) with 25%
oligodendrocyte cell loss in the latter. D and E: Hoechst staining of
both LGB can be seen, with 20% cell loss contralateral to the injured
nerve (same magnification, 10X).
Cell counting: The number of RGCs in the Thy1-CFP mice
was  quantified  by  ImageJ,  a  public  domain  Java  image
processing program (developed at the National Institutes of
Health, Washington, D.C.). To verify the findings, we stained
retinal flat mounts with Hoechst nuclear dye to examine nuclei
in the RGC layer. Under fluorescence microscopy, the RGC
number was assessed by averaging the RGC counts from at
least six fields that were equidistant from the optic nerve.
We  also  used  ImageJ  to  determine  the  number  of
oligodendrocyte cells in the optic nerve of the CNPase-GFP
mice. Three different sites, proximal to distal (from the globe
to the chiasm), were analyzed. In the axons, we were unable
to quantify the labeled RGC loss by direct calculation, so we
estimated  the  loss  relative  to  the  control  nerve  using  the
transgenic fluorescence labeling of the axons.
The total loss of labeled axons in the Thy1-CFP mice was
analyzed according to the final RGC loss measured in the
retinas. The findings were compared between injured and
control eyes at various time points after the induction of injury.
RESULTS
Crush model:
Thy1-CFP  transgenic  mice—In  the  Thy1-CFP  mice
with crush injury, the proportion of axonal cell loss increased
gradually and steadily over time compared to the left eye
(Figure 1A), from 30% on day 4 (Figure 1B) to 60% on day
7 and to 75% (maximum) on day 14 (Figure 1C). No change
was noted between day 14 and day 21 (75%–77% cell loss,
Table 1). No damage to the axons of the optic nerve was
detected in the control eyes (Figure 1A). Hoescht staining
revealed direct loss of oligodendrocytes (Table 1) to a lesser
degree than the reduction in CFP expression at same time
point (Figure 1). The early downregulation of CFP appeared
to  be  indicative  of  oligodendrocyte  dysfunction,  followed
later by cell death.
RGC quantification in the flat-mounted retinas (Table 1)
revealed a 17%–27% cell loss on day 4 after crush injury
(Figure 2B) compared to the control eyes (Figure 2A). This
loss increased to 50% on day 7 (Figure 2C) and to 75%
(maximum) on days 14 (Figure 2D) and 21.
CNPase-GFP transgenic mice—Histological study of
the  samples  from  the  GFP-labeled  mice  showed  30%
oligodendrocyte cell loss on day 4 after crush injury. This rate
increased to 40% on day 7 and to a maximum of 50% on days
14 and 21 compared to the untreated eyes (Table 1). The
fluorescence signal from the axonal fibers originating from
the right injured nerves was lower than that from the left
(untreated) nerves (Figure 3A). At that time point (14 days),
signs of damage could also be seen in the contralateral lateral
geniculate body of the crushed nerve (Figure 3C,E), which
had 25% fewer cells than its counterpart in the untreated nerve
(Figure 3B,D).
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this study, no significant axonal loss was detected at 4, 7, and
14  days  after  rAION  induction.  Examination  at  21  days
yielded a maximal axonal loss of 25% (Figure 4B). No axonal
loss could be detected in the untreated control eyes (Figure
4A). Accordingly, RGC quantification in the flat-mounted
retinas showed no significant cell loss at any time before 21
days,  when  a  25%  decrease  was  noted  compared  to  the
untreated control eyes (Figure 4C,D; Table 2).
No significant oligodendrocyte loss was detected before
21  days,  when  findings  yielded  a  decrease  of  20%–30%
compared to controls (Figure 4E,F; Table 2).
Apoptosis assay: After crush injury, TUNEL-positive nuclei
were detected mainly in the retinal sections, in the RGC layer.
The estimated rate of labeled cell bodies was 25% at 1 day
after injury and 40% after 3 days (Figure 5C). TUNEL-labeled
cells  were  also  found  in  the  retinal  sections  after  rAION
induction, but at lower levels: an estimated 5% on day 1 and
20% on day 3 (Figure 5B; Table 2). At 7 days following both
crush and rAION induction, there were no detectable TUNEL-
positive cells in the retina (data not shown). No TUNEL-
positive cells were observed in the retinal sections of the
untreated eyes (Figure 5A).
TUNEL-positive nuclei in the optic nerves were detected
mainly  following  crush  injury  (Figure  6C).  Staining  for
TUNEL of GFP-CNPase axons revealed a double labeling of
cells, confirming that the oligondendrocyte loss follows the
apoptosis pathway (Figure 6D,E). TUNEL-labeled cells were
detected in the damaged area behind the globe one day after
injury, with a few apoptotic cells further along the nerve on
day 3 (Figure 6). Bleeding could be seen in the center of the
damaged area, in addition to oligodendrocyte loss (Figure
6F,G). Following rAION induction, a few apoptotic cells were
detected anteriorly in the optic nerve, just behind the globe,
Figure  4.  Retinal  and  optic  nerve
findings  at  various  intervals  after
rAION  induction.  A:  Control  optic
nerve  from  Thy1-CFP  transgenic
mouse; no axonal loss is detected. B:
Histologicial section of the optic nerve
at  21  days  after  rAION  induction;
arrows  point  to  moderate  axonal  loss
(maximal,  25%).  C:  Flat-mounted
retina from control (untreated) eye of
same mouse showing normal density of
RGC  nuclei.  D.  Flat-mounted  retina
from study eye showing RGC loss, as
compared  to  control  (C).  E:
Histological  section  of  control
(untreated) optic nerve from CNPase-
GFP  transgenic  mouse.  Note  the
complete myelinization and number of
oligodendrocyte nuclei. F: Twenty-one
days after rAION induction, maximal
(20%–30%)  oligodendrocyte  loss  is
demonstrated.
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rAION model:with a peak on day 3 after induction of injury (Figure 6H,I).
No apoptotic cells were detected in the control left eye (Figure
6A).
DISCUSSION
This  study  demonstrates  the  progression  of  axonal
involvement  and  demyelination  along  the  optic  nerve
following crush injury or rAION. We used 2 murine models
of injury to compare different intensities of damage, and 2
types of transgenic mice to compare the pathophysiologic
effects at different levels.
Given that Thy1 in the retina is expressed selectively in
the axons and cell bodies of RGCs [25], fluorescence labeling
makes it possible to directly identify the cells microscopically
in the retinal ganglion layer and to perform a semiquantitative
analysis (as almost all the cells are labeled) [14]. Because this
method  eliminates  the  need  for  further  histological
processing,  it  appears  to  be  advantageous  to  other  dye-
labeling  methods  which  may  harbor  technical  difficulties
[14]. Its use is supported by the compatible results found in
the present study between the change in Thy1 mRNA retinal
expression  on  molecular  analysis  and  RGC  reduction  on
histological analysis in Thy1-CFP-labeled mice after rAION
induction.
Our finding of greater RGC loss and axonal damage in
the Thy1-CFP mice subjected to crush injury compared to the
Thy1-CFP mice subjected to rAION induction indicated that
the crush injury caused more damage than rAION. In both
models, the damage progressed within days, and axonal loss
could be detected up to the contralateral lateral geniculate
TABLE 2. DETECTION OF CELL LOSS IN THE RETINA AND OPTIC NERVE IN BOTH MODELS OF INJURY, BY FLUORESCENCE LABEL VERSUS
NUCLEI STAINING (HOECHST) AND TUNEL.
Models of injury
CRUSH 
(±SD)
rAION 
(±SD)
Retina RGC loss Thy1-CFP mice
(n=20)
CFP 21 d (n=5)            77.4 (±7.4) 25.3 (±9.5)
Hoechst 21d (n=5) 69.5 (±3.3)              22.9 (±14.7)
TUNEL            apoptotic 1d/3d (n=5) 25% 40%             5%      20%
Optic nerve OLG loss CNPase-GFP mice
(n=20)
CNPase 21d
(n=5)
52.3 (±8.6) 27.4 (±4.6)
Hoechst 21d (n=5) 51.1 (±5.3) 20.3 (±7.2)
Comparison of cell loss in the retina and optic nerve in both models of injury, by fluorescence (CFP or GFP) versus nuclei
staining  (Hoechst), at day 21. Our finding of greater RGC loss and axonal damage in the Thy1-CFP mice subjected to crush
injury compared to the Thy1-CFP mice subjected to rAION induction indicated that the crush injury caused more damage than
rAION. In both models, the damage progressed within days, and loss of oligodendrocytes could be detected on day 21, more in
the crush model. We were also able to show that the optic nerve injury, induced in both crush and rAION models, led to
anterograde RGC apoptosis. Apoptosis assays (TUNEL) at days 1 and 3 indicate apoptotic mechanism of the retinal ganglion
cell loss, increasing towards day 3. Maximal RGC loss (irreversible loss) calculated for day 21 showed 77.4% in the crush
model, and 25.3% for the rAION model.
Figure 5. Apoptosis assay: retina. A: Control (untreated) eye; no staining for apoptosis was detected. B: Three days after rAION induction,
TUNEL staining yielded positive cells along the retina C: Three days after crush injury, more positive cells were detected. D: Retinal section
served for positive control of the apoptosis assay.
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n=40% n=40 %body–the first synapsing nucleus for axons originating in the
RGCs on their way to the visual cortex (Figure 3B,C). We
were  also  able  to  show  that  the  axonal  damage  led  to
anterograde  RGC  loss  within  days,  reaching  maximum
(irreversible loss) between days 14 and 21 (Table 2).
After rAION induction, RGC and axonal loss reached
25% of baseline at 21 days. Molecular analysis with real-time
PCR revealed Thy1 levels of expression declined by 27% at
the same time point (data from previous studies not shown).
By contrast, the more intense damage induced by the
crush injury led to a 27% decrease in RGC level by 4 days
after injury, and a 77% RGC loss by 14 days, with no further
retinal damage. This finding is consistent with the 20% loss
in mRNA Thy1 expression reported by Schlamp et al. [20].
Huang et al. [19] noted a greater (50%) decrease in Thy1 gene
expression at 5 days after crush injury, but they used a rat
model,  so  the  difference  could  be  attributable  to  species
variation.
We found the same amount of axonal loss and RGC loss
at all time points after crush injury. This finding indicates that
axonal loss may occur concurrently with RGC loss after crush
injury.
Our  second  group  of  transgenic  mice  expressed  the
CNPase  gene  promoter  linked  to  GFP  and  was  used  to
evaluate the changes in oligodendrocytes in response to the
two intensities of optic nerve injury. The findings in this group
complemented those in the first group, clearly demonstrating
the  time  and  order  of  events.  We  noted  a  greater  (30%)
decrease in fluorescence in the optic nerve (oligodendrocytes
and myelin) than in the retina (RGCs) at the early stage of
injury (4 days), indicating that the optic nerve is affected
simultaneously if not primarily. This agrees with studies of
other  demyelinating  diseases  wherein  loss  of
oligodendrocytes and myelin apparently led to axonal loss
[15,26,27].
TUNEL staining supported these findings, showing that
in both models of injury, apoptosis occurred shortly after the
damage was induced, simultaneously in the optic nerve and
retina. There was more apoptosis after crush than after rAION
injury,  because  rAION  is  a  more  gentle  injury.  Positive
apoptotic cells were detected 3 days after damage. By contrast,
Berkelaar et al. [28] first detected apoptotic cells only 5 days
after damage. However, they induced intracranial lesions 8–
9 mm from the eye whereas, in our rAION model, damage
was induced to the head of the optic nerve, and in our crush
model, proximal to the globe of the eye. This may explain the
earlier apoptotic pathway in our study. In line with our study
results are the long interval between the axonal injury and
RGC death in the earlier report [28] and the different times of
onset of the massive RGC loss with optic nerve lesions near
or far from the eye. We speculate that the more severe crush
injury may have led to immediate apoptosis or even damage
to the area by necrosis. Further studies are needed to clarify
this  issue.  The  presence  of  a  feedback  effect  is  also  still
Figure 6. Apoptosis assay: optic nerve, after crush and rAION. A: Normal optic nerve; no apoptotic cells are detected. B: Positive control. C:
TUNEL-positive (red) cells along the optic nerve 3 days following crush injury of wild type mice. D: TUNEL staining of optic nerve of GFP-
CNPase mice 3 days following crush showing positive staining. Oligodendrocytes apoptotic cells are yellow (green for GFP and red represent
positive staining for apoptosis), suggesting that oligodendrocytes in the optic nerve proximal to the globe undergo apoptosis 3 days following
induction of crush injury. E: The whole optic nerve of same GFP-CNPase mice (D) is shown. F: Optic nerve head, 3 days following crush
injury; showing hemorrhage (asterisk), immediately posterior to the globe. G: Same damaged area at higher magnification, demonstrating
loss of oligodendrocytes and focal hemorrhagic area. H: Optic nerve head 3 days following rAION induction, showing preserved architecture
of retina and intraocular optic nerve, without apoptotic cells. I: Same nerve as H, 3 days after rAION, demonstrating the anterior segment of
the optic nerve behind the globe. Note few TUNEL-positive cells (red staining, arrows) at the center of the anterior optic nerve.
Molecular Vision 2008; 14:2171-2179 <http://www.molvis.org/molvis/v14/a254> © 2008 Molecular Vision
2177unclear, with damage to the axons causing oligodendrocyte
loss. Clearly, axonal damage places stress on the cell bodies
in the retina.
Better  understanding  of  the  pathophysiology  of  optic
nerve  damage  might  aid  the  development  of  targeted
neuroprotective agents.
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